You're not alone in this.

Yes. TaperMeds follows evidence-based protocols from the Maudsley Deprescribing Guidelines, NICE guidance, and the Ashton Manual. Our taper algorithms are built on published hyperbolic tapering principles and clinical withdrawal literature. You maintain full clinical authority to modify any plan.

TaperMeds works for psychiatrists, primary care physicians, and nurse practitioners who want to support patients through medication tapers. Whether you're starting your first deprescribing case or scaling an established program, the platform adapts to your workflow.

Currently supports psychiatric medications including SSRIs, SNRIs, benzodiazepines, antipsychotics, and mood stabilizers. We're continuously expanding medication coverage based on clinical demand and published deprescribing protocols.

Initial taper planning goes from 2 hours to 3 minutes. But the real benefit is in your follow-up visits: patients track symptoms in the app, so you spend check-ups on clinical decisions, not trying to reconstruct what happened or taking notes.

Patients get a simple app to track symptoms, sleep, and medication doses. You review aggregated data and patterns when convenient. Patients report feeling more supported between visits, and you get better longitudinal data to inform clinical decisions.

Yes. All patient data is encrypted, and stored securely. You own your patient data. We never sell or share clinical information with third parties. Full details in our privacy policy and BAA.